Antibiotic tested to clear 'Liver brain Fog'
NCT ID NCT04244877
Summary
This study aimed to see if the antibiotic rifaximin could improve subtle thinking problems (covert hepatic encephalopathy) in people with liver cirrhosis, especially when those problems are linked to an overgrowth of gut bacteria. The plan was to treat about 40 patients for eight weeks and measure changes in their brain function tests and gut motility. The trial was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS, LIVER are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.